Close Menu

NEW YORK – Horizon Discovery Group reported on Monday that its total revenues as reported for the first half of 2019 rose 14 percent, thanks to large increases in revenues from its bioproduction and screening business units.

For the six months ended June 30, the gene editing and gene modulation technologies company reported total revenues of £28.6 million ($35.6 million), up from £25.1 million in the first half of 2018. On a constant currency basis, revenues rose 9 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.